Vaishali Pharma Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 131.91 million compared to INR 196.62 million a year ago. Revenue was INR 138.95 million compared to INR 202.26 million a year ago. Net income was INR 19.94 million compared to INR 14.02 million a year ago. Basic earnings per share from continuing operations was INR 1.89 compared to INR 1.33 a year ago. Diluted earnings per share from continuing operations was INR 1.89 compared to INR 1.33 a year ago.
For the six months, sales was INR 228.55 million compared to INR 278 million a year ago. Revenue was INR 245.09 million compared to INR 290.63 million a year ago. Net income was INR 35.05 million compared to INR 22.13 million a year ago. Basic earnings per share from continuing operations was INR 3.32 compared to INR 2.1 a year ago. Diluted earnings per share from continuing operations was INR 3.32 compared to INR 2.1 a year ago.